Skip to main content
Clinical Trials/CTRI/2021/12/038779
CTRI/2021/12/038779
Completed
未知

Efficacy of digital therapeutic intervention via MAP (Mobile health Application Phablecare) in Indian adults with Uncontrolled Hypertension: A 12-week prospective single arm study. - MAP

Terrals Technologies Pvt Ltd0 sites125 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Sponsor
Terrals Technologies Pvt Ltd
Enrollment
125
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 19, 2022
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Terrals Technologies Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\.Male or female patients aged ââ?°Â¥ 30 to 65 years.
  • 2\.Able to give written informed consent.
  • 3\.Diagnosed and under treatment cases of Primary Hypertension, with Blood Pressure levels either \> 140 mmHg systolic or \> 90 mmHg diastolic.
  • 4\.Grades of Hypertension: Grade 1, 2, and 3(ESC/EHS Guidelines).
  • 5\.Owning a smart phone and the ability to use it, sufficient literacy, aspiration to participate in the trial.
  • 6\.With or without other comorbidities such as coronary heart disease, diabetes, hyperlipidaemia etc

Exclusion Criteria

  • 1\.Patients associated with any other Hypertension/Chronic Disease intervention program via digital therapeutic channels.
  • 2\.Illiteracy and no ability to use smart phone.
  • 3\.Bedridden and/or severely compromised patients (Chronic kidney disease, HIV, post\-surgery, Covid, severe cardio pulmonary disorders etc.)
  • 4\.Pre and post\-partum women.
  • 5\.Handicap restricting physical movements.
  • 6\.Patients who received previous such digital therapeutic intervention.

Outcomes

Primary Outcomes

Not specified

Similar Trials